Gene: TCEA3
Official Full Name: transcription elongation factor A3provided by HGNC
Gene Summary: Predicted to enable DNA binding activity; translation elongation factor activity; and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35120 | TCEA3 Knockout cell line (HeLa) | Human | TCEA3 | 1:3~1:6 | Negative | Online Inquiry |
KO35121 | TCEA3 Knockout cell line (HCT 116) | Human | TCEA3 | 1:2~1:4 | Negative | Online Inquiry |
TCEA3 Gene Knockout Cell Lines are specialized cell lines developed using cutting-edge gene editing techniques, specifically CRISPR-Cas9, to create targeted deletions in the TCEA3 gene. This gene is known to play a pivotal role in various cellular processes, including RNA transcription and processing, making these knockout cell lines invaluable tools for researchers studying gene function, signaling pathways, and cellular metabolism.
These cell lines operate through a mechanism of specific gene disruption, allowing scientists to observe the resultant phenotypic and functional changes in cells lacking functional TCEA3. By investigating these alterations, researchers can gain critical insights into the gene's role in disease models, such as cancer or neurological disorders, enabling the identification of potential therapeutic targets or biomarkers. The ability to study these changes in a controlled environment also enhances the efficiency and accuracy of experimental results.
From a scientific perspective, TCEA3 Gene Knockout Cell Lines are crucial for advancing research in molecular biology and genetics. Their applications range from understanding gene interactions to validating drug responses in precision medicine. These cell lines provide an irreplaceable resource for both academic and clinical researchers aiming to elucidate the complex interplay of genes in health and disease.
One of the significant advantages of our TCEA3 Gene Knockout Cell Lines lies in their precision and reproducibility compared to traditional knockdown methods. They offer a stable and complete loss of function, which is essential for long-term studies and provides clearer results than transient knockdown techniques. Furthermore, our cell lines come with comprehensive characterization data, ensuring that users have reliable background information and thus enhancing the credibility of their research findings.
In conclusion, TCEA3 Gene Knockout Cell Lines exemplify our commitment to providing high-quality, innovative products that empower researchers and clinicians alike. With a focus on precision and application-specific design, our offerings are backed by extensive expertise and support, helping our customers push the boundaries of their research and clinical discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.